Bedrijfsvoering Bristol-Myers Squibb Company

BMY

US1101221083

Farmaceutische producten

Geschatte realtime Cboe BZX Andere beurzen 22:00:00 21-01-2025			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
57,41 ^USD	+1,99%		+2,25%	+0,77%

17/01	Novo Nordisk's Ozempic, Wegovy onder de medicijnen die zijn uitgekozen voor Amerikaanse Medicare-prijsbesprekingen	MT
17/01	Novo Nordisk's Ozempic, Wegovy onder de medicijnen die zijn uitgekozen voor Amerikaanse Medicare-prijsbesprekingen	MT

Uitvoerend comité: Bristol-Myers Squibb Company

Bedrijfsleider

Beklede functiesVan

Christopher Boerner

54 jaar

Chief Executive Officer

01-11-2023

Sandra Leung

64 jaar

General Counsel

01-01-2007

Estelle Vester-Blokland

Chief Tech/Sci/R&D Officer

Robert Plenge

54 jaar

Chief Tech/Sci/R&D Officer

01-11-2019

Phil Holzer

49 jaar

Comptroller/Controller/Auditor

01-01-2015

Greg Meyers

Chief Tech/Sci/R&D Officer

Catalina Vargas

Human Resources Officer

David Elkins

57 jaar

Director of Finance/CFO

20-11-2019

Samit Hirawat

56 jaar

Chief Tech/Sci/R&D Officer

01-01-2019

Kimberly McCutcheon Jablonski

Compliance Officer

01-10-2023

Samenstelling van de raad van bestuur: Bristol-Myers Squibb Company

Directeur

RadenVan

Christopher Boerner

54 jaar

Chairman

01-04-2024

Theodore Samuels

70 jaar

Audit Committee	21-02-2017
Governance Committee Chair
Compensation Committee	01-01-2022
HR Committee	01-01-2022
Finance Committee	17-07-2023
Governance Committee	17-07-2023
Nominating Committee	17-07-2023

Paula Price

64 jaar

Compensation Committee	09-05-2014
HR Committee	09-05-2014
Audit Committee Chair	01-01-2022
Audit Committee
Governance Committee

Derica Rice

60 jaar

Audit Committee Chair
Compensation Committee
Audit Committee	22-07-2021
Finance Committee	31-08-2020

Phyllis Yale

67 jaar

Governance Committee Chair	11-07-2016
Nominating Committee Chair	11-07-2016
Audit Committee
Governance Committee	05-12-2019

Manuel Hidalgo Medina

57 jaar

Governance Committee	17-07-2024
Nominating Committee	17-07-2024

Julia Haller

70 jaar

Governance Committee	11-08-2022
Nominating Committee	11-08-2022

Michael McMullen

64 jaar

Compensation Committee	24-07-2023
Audit Committee	01-07-2024

Karen Vousden

67 jaar

Compensation Committee

01-01-2018

Deepak Bhatt

57 jaar

Compensation Committee

14-06-2022

Peter Arduini

60 jaar

Compensation Committee

01-04-2016

Recente benoemingen: Bristol-Myers Squibb Company

Verastem Oncology benoemt Matthew E. Ros tot Chief Operating Officer	15/01	CI
Annexon, Inc. Benoemt William ?BJ? Jones tot lid van de Raad van Bestuur	10/01	CI
Lexicon Pharmaceuticals, Inc. Benoemt Scott Coiante tot Senior Vice President	02/01	CI
CytoDyn benoemt Max Lataillade tot Senior Vice President en Hoofd Klinische Ontwikkeling	08-10-24	CI
Inozyme Pharma, Inc. kondigt de benoeming aan van Erik Harris tot lid van de Raad van Bestuur	07-10-24	CI
Acadia Pharmaceuticals benoemt Catherine Adams tot CEO	23-09-24	MT
Lincoln Financial meldt overlijden van bestuurslid Michael F. Mee	18-09-24	CI

Meer nieuws

Voormalige zaakvoerders en bestuurders: Bristol-Myers Squibb Company

Insider

Beklede functies

VanTot

Vicki Sato

Director/Board Member	11-07-2006	04-05-2021
Independent Dir/Board Member	11-07-2006	04-05-2021

Michael Grobstein

Director/Board Member	06-03-2007	05-05-2020
Independent Dir/Board Member	06-03-2007	05-05-2020

John E. Elicker

Investor Relations Contact	01-01-2000	31-03-2020
Public Communications Contact	01-01-2000	06-01-2020

Joseph C. Caldarella

Comptroller/Controller/Auditor

01-01-2010

15-02-2018

Laurie Glimcher

Director/Board Member	01-01-1997	21-07-2017
Independent Dir/Board Member	01-01-1997	21-07-2017

Lamberto Andreotti

Director/Board Member	01-01-2009	01-01-2015
Chief Executive Officer	04-05-2010	05-05-2015
Chairman	01-01-2015	02-05-2017
Chief Operating Officer	01-05-2008	01-05-2010
Corporate Officer/Principal	01-01-1998	01-05-2008

James Cornelius

Chief Executive Officer	12-09-2006	04-05-2010
Chairman	01-09-2006	05-05-2015
Independent Dir/Board Member	01-01-2005	05-05-2015
President	01-09-2006	14-02-2013

John E. Celentano

Human Resources Officer	13-05-2011	08-10-2012
Public Communications Contact	13-05-2011	08-10-2012
Corporate Officer/Principal	01-01-2000	01-07-2013

Charles Sigal

Director/Board Member	03-03-2011	01-06-2013
Chief Tech/Sci/R&D Officer	01-10-2004	01-06-2013

Robert Williams

Director/Board Member	11-09-2006	31-05-2013
Independent Dir/Board Member	12-05-2011	31-05-2013

Louis J. Freeh

Director/Board Member	01-01-2005	07-03-2013
Independent Dir/Board Member	11-05-2011	07-03-2013

Anthony Hooper

Chief Operating Officer	13-05-2011	20-10-2011
Corporate Officer/Principal	01-01-1996	13-05-2011

Leif Valdemar Johansson

Director/Board Member	01-01-1998	20-09-2011
Independent Dir/Board Member	11-05-2011	20-09-2011

Carlo de Notaristefani

Corporate Officer/Principal

01-01-2004

01-07-2011

Blaine Davis

Corporate Officer/Principal

01-01-2005

01-05-2008

Stephen E. Bear

Human Resources Officer

01-01-2001

31-03-2008

Richard K. Willard

General Counsel

01-01-2005

11-05-2007

Andrew Bonfield

Director of Finance/CFO

01-01-2002

01-01-2007

David J. Helfgott

Chief Operating Officer	15-11-2006	-
President	15-11-2006	-

Louis Sullivan

Director/Board Member

02-05-2006

Louis Gerstner

Director/Board Member	-	02-05-2006
Independent Dir/Board Member	-	02-05-2006

Donald Hayden

Corporate Officer/Principal

01-01-1981

01-01-2006

John L. McGoldrick

General Counsel

01-01-1995

01-10-2005

Robert T. Zito

Public Communications Contact

01-06-2004

Edward M. Dwyer

Treasurer

01-01-2004

Dean Mitchell

Corporate Officer/Principal

01-01-2001

01-01-2004

Juan F. Sanchez

Corporate Officer/Principal

01-11-2003

Marino Carol

Corporate Officer/Principal

01-09-1995

01-01-2003

Richard L. Wolgemuth

General Counsel

01-01-2003

Fabio M. Benedetti

Chief Tech/Sci/R&D Officer

01-07-1999

01-05-2002

Steven E. Benner

Chief Tech/Sci/R&D Officer

01-01-1995

01-01-2002

Stacey M. Lituchy

Corporate Officer/Principal

31-12-2001

Gary Dickinson

Human Resources Officer

01-01-1997

01-04-2001

David L. Zabor

Corporate Officer/Principal

01-01-2001

Stacey Latuche

Portfolio Manager-Equities

31-12-2000

Robert L. Simon

General Counsel

01-01-1987

01-07-2000

Jaisim Shah

Sales & Marketing

01-07-1997

01-07-2000

Ronald Pepin

Chief Tech/Sci/R&D Officer

01-03-1990

01-07-2000

Myrtle Potter

Corporate Officer/Principal

01-01-1996

01-05-2000

Andrew Bodnar

Chief Tech/Sci/R&D Officer

01-01-2000

Kin Yip Leung

Corporate Officer/Principal

01-01-1990

01-02-1999

Nicole Onetto

Chief Tech/Sci/R&D Officer

01-07-1991

01-05-1997

Joachim von Roy

Corporate Officer/Principal

01-01-1997

Kenneth Anderson

Sales & Marketing

01-01-1980

01-01-1997

William Scott

Corporate Officer/Principal

01-01-1990

31-12-1996

N. Coles

Corporate Officer/Principal

01-01-1996

Robert B. Ross

Corporate Officer/Principal

01-01-1991

31-12-1994

Patrick J. Fortune

Corporate Officer/Principal

01-12-1991

01-08-1994

Mark J. Carvlin

Sales & Marketing

01-01-1989

31-12-1993

Lawrence Hamilton

Chief Administrative Officer	01-01-1985	01-08-1993
Human Resources Officer	01-01-1985	01-08-1993

Barry Wilson

Corporate Officer/Principal

01-01-1980

01-01-1993

Henry Y. Pan

Corporate Officer/Principal

01-01-1985

01-01-1992

Steven Ratoff

Director of Finance/CFO	01-01-1975	01-01-1991
Corporate Officer/Principal	01-01-1975	-

George Zavoico

Corporate Officer/Principal

01-01-1988

Robert A. Fildes

Chief Operating Officer

01-01-1975

01-01-1980

Guo Wei Wang

Corporate Officer/Principal

Mark Gleason

Corporate Officer/Principal

Robert Laurenzo

Corporate Officer/Principal

H. Perry Fell

Corporate Officer/Principal

Alexander MacPherson

Corporate Officer/Principal

Jonas Wang

Corporate Officer/Principal

Steven Girgenti

Corporate Officer/Principal

Jerry Frantz

Sales & Marketing

Salvatore Forenz

Director/Board Member

Sales & Marketing

Sales & Marketing

Treasurer

Chief Tech/Sci/R&D Officer	-	-
President	-	-

Arthur C. Louie

Corporate Officer/Principal

Jay Moorin

Corporate Officer/Principal

Anthony Plohoros

Public Communications Contact

Ronald Thiboutot

Corporate Officer/Principal

Paul Karr

Comptroller/Controller/Auditor

Andrew Forman

Corporate Officer/Principal

John L. Skule

Public Communications Contact

Greg W. Cashman

Director of Finance/CFO

31-12-1995

Dan R. Burns

Corporate Officer/Principal

Leeftijdsdistributie van bedrijfsleiders

Ratio vrouwen/mannen

Man	26
Vrouw	11

Waarvan leden van het uitvoerend comité

Man	6
Vrouw	4

Waarvan bestuurders

Man	9
Vrouw	2

ESG MSCI

ESG

Milieu

Sociaal

Bedrijfsvoering

Controverse

Bristol-Myers Squibb Company is gespecialiseerd in de ontwikkeling, de vervaardiging en de verkoop van farmaceutische producten. De producten zijn bestemd voor de behandeling van kanker, hart- en vaatziektes, hepatitis, immuunziektes en psychiatrische stoornissen. 70,1% van de omzet wordt gemaakt in de Verenigde Staten.

Werknemers

34.100

Sector

Farmaceutische producten

Agenda

06-02-2025 - Q4 2024 Cijferpublicaties

Meer informatie over het bedrijf